Beta-block  	Beta-block  	 JJ	B-NP
the  	the  	 DT	O
septic  	septic  	 JJ	B-NP
heart  	heart  	 NN	I-NP
Cardiac  	Cardiac  	 NNP	I-NP
depression  	depression  	 NN	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
well-described  	well-described  	 JJ	O
manifestation  	manifestation  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
sepsis  	sepsis  	 JJ	O
syndrome 	syndrome 	 NN	O
.  	.  	 .	O
An  	An  	 DT	O
important  	important  	 JJ	O
underlying  	underlying  	 JJ	O
mechanism  	mechanism  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
attenuation  	attenuation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
adrenergic  	adrenergic  	 JJ	I-NP
response  	response  	 NN	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
cardiomyocyte  	cardiomyocyte  	 JJ	B-NP
level 	level 	 NN	I-NP
.  	.  	 .	O
By  	By  	 IN	O
reducing  	reducing  	 VBG	O
their  	their  	 PRP$	O
cell-specific  	cell-specific  	 JJ	B-NP
function  	function  	 NN	I-NP
( 	( 	 -LRB-	O
contractility 	contractility 	 LS	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
cardiomyocytes  	cardiomyocytes  	 NN	B-NP
reduce  	reduce  	 VB	O
their  	their  	 PRP$	O
energy  	energy  	 NN	B-NP
expenditure 	expenditure 	 NN	I-NP
.  	.  	 .	O
Consequently 	Consequently 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
cardiac  	cardiac  	 JJ	B-NP
myocytes  	myocytes  	 NNS	I-NP
survive  	survive  	 VBP	O
in  	in  	 IN	O
a  	a  	 DT	O
hibernation-like  	hibernation-like  	 JJ	B-NP
state  	state  	 NN	I-NP
as  	as  	 IN	O
long  	long  	 JJ	O
as  	as  	 IN	O
intracellular  	intracellular  	 JJ	B-NP
energy  	energy  	 NN	I-NP
generation  	generation  	 NN	I-NP
is  	is  	 VBZ	O
limited 	limited 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
objective  	objective  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
review  	review  	 VB	O
β-blocker  	β-blocker  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
septic  	septic  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
MEDLINE  	MEDLINE  	 NNP	B-NP
database 	database 	 NN	I-NP
.  	.  	 .	O
During  	During  	 IN	O
established  	established  	 JJ	O
sepsis  	sepsis  	 NN	O
with  	with  	 IN	O
organ  	organ  	 JJ	B-NP
failure 	failure 	 NN	I-NP
,  	,  	 ,	O
external  	external  	 JJ	B-NP
adrenergic  	adrenergic  	 JJ	I-NP
stimulation  	stimulation  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
heart  	heart  	 NN	O
must  	must  	 MD	O
be  	be  	 VB	O
kept  	kept  	 VBN	O
at  	at  	 IN	O
a  	a  	 DT	O
minimum 	minimum 	 NN	O
.  	.  	 .	O
To  	To  	 TO	O
blunt  	blunt  	 VB	O
the  	the  	 DT	O
adrenergic  	adrenergic  	 JJ	B-NP
response 	response 	 NN	I-NP
,  	,  	 ,	O
β-blockers  	β-blockers  	 NNS	B-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
used  	used  	 VBN	O
in  	in  	 IN	O
several  	several  	 JJ	O
preclinical  	preclinical  	 NN	B-NP
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
studies 	studies 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
septic  	septic  	 JJ	B-NP
animals 	animals 	 NNS	I-NP
,  	,  	 ,	O
β-blockers  	β-blockers  	 JJ	B-NP
reduced  	reduced  	 JJ	O
heart  	heart  	 NN	B-NP
rate 	rate 	 NN	I-NP
,  	,  	 ,	O
whereas  	whereas  	 IN	O
stroke  	stroke  	 JJ	B-NP
volume  	volume  	 NN	I-NP
was  	was  	 VBD	O
maintained 	maintained 	 VBN	O
.  	.  	 .	O
Esmolol  	Esmolol  	 NNP	B-NP
in  	in  	 IN	O
vivo  	vivo  	 NN	B-NP
prevented  	prevented  	 VBD	O
the  	the  	 DT	O
downregulation  	downregulation  	 NN	B-NP
of  	of  	 IN	I-NP
adrenergic  	adrenergic  	 JJ	I-NP
pathways 	pathways 	 NN	I-NP
,  	,  	 ,	O
preserving  	preserving  	 VBG	O
full  	full  	 JJ	O
cardiac  	cardiac  	 FW	B-NP
function  	function  	 FW	I-NP
ex  	ex  	 FW	I-NP
vivo 	vivo 	 FW	I-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
β-blockers  	β-blockers  	 NNP	B-NP
reduced  	reduced  	 VBD	O
the  	the  	 DT	O
inflammatory  	inflammatory  	 JJ	B-NP
response  	response  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
degree  	degree  	 NN	O
of  	of  	 IN	O
lung  	lung  	 NN	B-NP
injury 	injury 	 NN	I-NP
.  	.  	 .	O
Some  	Some  	 DT	O
animal  	animal  	 NN	O
studies  	studies  	 NNS	O
documented  	documented  	 VBN	B-NP
survival  	survival  	 NN	I-NP
benefits 	benefits 	 NNS	I-NP
,  	,  	 ,	O
particularly  	particularly  	 RB	O
when  	when  	 WRB	O
β-blockers  	β-blockers  	 NNP	B-NP
were  	were  	 VBD	O
administered  	administered  	 VBN	O
before  	before  	 IN	O
the  	the  	 DT	O
septic  	septic  	 JJ	B-NP
insult 	insult 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
septic  	septic  	 JJ	B-NP
shock 	shock 	 NN	I-NP
,  	,  	 ,	O
blood  	blood  	 NN	O
pressure  	pressure  	 NN	O
increased  	increased  	 VBN	O
and  	and  	 CC	O
cardiac  	cardiac  	 JJ	B-NP
indices  	indices  	 NNS	I-NP
remained  	remained  	 VBD	O
stable  	stable  	 JJ	O
with  	with  	 IN	O
metoprolol  	metoprolol  	 JJ	B-NP
administration 	administration 	 NN	I-NP
.  	.  	 .	O
Preclinical  	Preclinical  	 NNP	B-NP
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
with  	with  	 IN	O
β-1  	β-1  	 CD	O
receptor  	receptor  	 NN	O
blockers  	blockers  	 NN	O
during  	during  	 IN	O
sepsis  	sepsis  	 NNS	O
show  	show  	 VBP	O
promising  	promising  	 VBG	B-NP
results 	results 	 NNS	I-NP
.  	.  	 .	O
Future  	Future  	 JJ	O
studies  	studies  	 NNS	O
are  	are  	 VBP	O
needed  	needed  	 VBN	O
to  	to  	 TO	O
establish  	establish  	 VB	O
the  	the  	 DT	O
optimal  	optimal  	 JJ	B-NP
dose  	dose  	 NN	I-NP
and  	and  	 CC	O
timing  	timing  	 NN	O
of  	of  	 IN	O
its  	its  	 PRP$	O
administration 	administration 	 NN	B-NP
.  	.  	 .	O
